MOTIVATION LETTER The EIC Women Leadership Programme exists to level a playing field that remains visibly uneven across European innovation. I have watched that unevenness from two vantage points: as a researcher building computational tools for drug discovery and neuroscience, and as a Nigerian pharmacist who has spent years working around infrastructure gaps that European founders rarely encounter. The programme's decision to recruit mentors from across the ecosystem, not just from the usual founder-investor pipeline, is what draws me to apply. My research career has been built on leading complex, interdisciplinary projects with minimal institutional support. The neurocascade project is the clearest example. I designed and built a receptor-to-behavior brain-circuit simulation engine that couples pharmacokinetics to receptor binding to Wilson-Cowan circuit dynamics to behavioral-readout ODE layers. The system covers three literature-calibrated receptor and circuit systems, mu-opioid, D2 dopamine, and GABA-A, with Bayesian calibration performed using PyMC. All 62 tests pass. The project required me to integrate pharmacology, dynamical systems theory, software engineering, and Bayesian statistics into a single coherent architecture, and to make design decisions about what could be calibrated from literature versus what needed to be labeled illustrative pending real behavioral data. That kind of cross-domain judgment is exactly what mentorship demands. I also bring a track record of building independent research infrastructure from scratch. I have constructed four separate DuckDB-based ingest-to-analyze pipelines across life sciences, technology and AI security, and social science domains. I self-host local LLM serving with llama.cpp and manage production systems operations including Linux VPS, systemd, Caddy TLS, and automated backup and disaster recovery. These are practical capabilities that let an independent researcher in Lagos or Potsdam produce work comparable to a well-funded lab. My commitment to supporting underrepresented innovators is practical. I have spent my career navigating the gap between what African researchers can access and what their peers in Europe and North America take for granted. I know what it costs to build without a safety net, and I know how to help others do the same. The EIC programme's mission to support the next generation of women leaders in European innovation aligns directly with my belief that the strongest research ecosystems are the ones that deliberately widen their own doors. I am currently enrolled in the M.Sc. Digital Health programme at the Hasso Plattner Institute and University of Potsdam, which places me physically in the European innovation ecosystem while my research remains globally oriented. I am prepared to commit the time and attention that serious mentorship requires, and I bring a multi-domain technical background that can help mentees navigate everything from scientific validation to infrastructure decisions. RESEARCH STATEMENT The neurocascade project is the research line I am putting forward for this programme, and it is the best fit because it demonstrates exactly what the EIC Women Leadership Programme seeks in a mentor: the ability to lead complex, interdisciplinary work, to make honest judgments about what is known versus what is assumed, and to build systems that others can use. Neurocascade is a receptor-to-behavior brain-circuit simulation engine. It couples four layers of modeling: pharmacokinetics, receptor binding, Wilson-Cowan circuit dynamics, and behavioral readouts. The system is implemented as coupled ODEs solved with RK45, with Bayesian calibration performed using PyMC. Three receptor and circuit systems are currently implemented: mu-opioid, D2 dopamine, and GABA-A. The project has 62 passing tests, and the circuit-layer parameters are explicitly labeled illustrative pending real behavioral-data fits. That labeling is deliberate. I built the system to be honest about the epistemic status of each parameter, which is a discipline I want to model for the women founders and innovators this programme supports. The project required me to make a series of strategic decisions about scope and validation. I chose to calibrate receptor-level parameters from the literature, which is defensible because those parameters have been measured repeatedly across decades of pharmacology. I chose to label circuit-level parameters as illustrative because the behavioral data needed to constrain them does not yet exist in a form I can access. That distinction matters. It is the difference between a model that overclaims and a model that can be extended by other researchers without inheriting hidden assumptions. My broader research record supports the same discipline. The CCT model, a tripartite pharmacological framework for reward-memory encoding prevention in addiction, is a coupled three-axis ODE model with Bayesian MCMC calibration using PyMC DEMetropolisZ across 14 free parameters. The priors were elicited from a systematic screen of 1,847 records. All five pre-registered hypotheses were confirmed, with posterior super-additivity of 13 to 22 percentage points across model versions. Three sole-authored preprints are under review at peer-reviewed journals. I have also produced negative results that I reported directly. A pre-registered, powered replication testing whether bipartite persistent homology predicts hERG cardiotoxicity found that topological features do not beat a plain descriptor baseline, AUROC 0.8426 versus 0.8782. A follow-up applying the same topological constructs to drug-resistance prediction found almost no signal, AUROC 0.425 and 0.485 on the Platinum benchmark. These results settled questions the literature had never actually run. I then pivoted to a sequence-representation approach, TOPOLOGIX, which uses ESM-2 protein-language-model delta-embeddings plus Morgan fingerprints and a Random Forest classifier. TOPOLOGIX achieves AUROC 0.804 plus or minus 0.025 on the Platinum benchmark across 553 mutations, and 0.634 on SKEMPI 2.0, beating structure-based baselines like mCSM-lig at approximately 0.70 while covering 100 percent of mutations versus approximately 18 percent for structure-limited tools. The ergofluids project, which extends Koopman-operator and Dynamic Mode Decomposition methods with a Mori-Zwanzig memory kernel for modeling drug-vehicle transport through tumor tissue, is pre-registered with a gated validation pipeline. The synthetic-data gates passed. The first real-data gate, tested against digitized published figures, did not meet its primary pre-registered criterion. I reported that result directly rather than reframing it. That is the standard of rigor I would bring to mentoring. For the EIC Women Leadership Programme, neurocascade is the strongest evidence of what I can offer. It is a live, working system that demonstrates cross-domain integration, honest validation, and the kind of architectural thinking that helps founders and innovators build things that scale. SHORT ANSWER ESSAY: MENTORSHIP PHILOSOPHY My mentorship philosophy is built on a single principle: teach people to know what they do not know. The most damaging failure mode in early-stage innovation is the inability to distinguish between what is validated, what is assumed, and what is unknown. I learned this the hard way in my own research. The ergofluids project passed its synthetic-data gates and then failed its first real-data gate. I reported the failure directly because the pre-registration demanded it. That experience taught me that the discipline of honest reporting is worth more than a polished narrative. I would bring this philosophy to the EIC Women Leadership Programme by helping mentees build explicit validation pipelines for their ideas. I have built four independent DuckDB-based ingest-to-analyze pipelines across different domains. I have self-hosted local LLM serving and managed production systems operations. These are practical skills that let a founder test assumptions cheaply and quickly. I would teach mentees to build the smallest possible test that can falsify their core assumption, and to run it before they build anything else. I also understand the specific challenges of building from the margins. I am a Nigerian pharmacist working in computational research, and I have spent my career navigating gaps in infrastructure, funding, and institutional support. I know what it costs to build without a safety net. I know how to stretch limited resources and how to find the one piece of infrastructure that matters most. I would bring that knowledge to every mentoring conversation. Finally, I would model intellectual honesty. The EIC programme is about leveling the playing field for women leaders in European innovation. That mission only works if the mentorship is grounded in reality, not in hype. I have published negative results. I have labeled my own model parameters as illustrative when they were. I have reported failed validation gates. I would expect the same rigor from the founders I mentor, and I would help them build the systems to achieve it. CHECKLIST - [ ] Complete official EIC Women Leadership Programme application form at the programme URL - [ ] Verify deadline of 30 April 2026 EOB on the programme website - [ ] Confirm eligibility as an independent researcher and current M.Sc. student under the programme's definition of experienced leader - [ ] Prepare CV tailored to mentorship and ecosystem leadership, emphasizing neurocascade and infrastructure-building experience - [ ] Gather contact details for references from collaborators (Kent Berridge, Samuel Gershman, Nathaniel Daw, Marcelo Mattar) if required - [ ] Prepare a one-page summary of the neurocascade project with architecture diagram for any supplementary materials - [ ] Draft responses to any additional form questions not covered by the materials above - [ ] Review final application for alignment with the programme's stated mission of supporting women leaders in European innovation EDITOR NOTES - Eligibility risk: the programme targets experienced leaders from Europe's innovation ecosystem, including founders, investors, and C-level executives. Eniola is early-career and currently an M.Sc. student. The application must lead with the neurocascade project and infrastructure-building record to make the case for seniority, and should explicitly address how his experience qualifies him despite not holding a founder or executive title. - The neurocascade circuit-layer parameters are labeled illustrative pending real behavioral-data fits. Do not claim validated behavioral predictions. The motivation letter and research statement above are careful about this, but any verbal explanation or supplementary material must maintain the same distinction. - Verify the programme's definition of mentor eligibility regarding geographic scope. Eniola is Nigerian and currently enrolled in Germany. The programme is European, but it is unclear whether non-EU nationals are eligible. This must be confirmed before submission. - The profile lists employment at Synthcare as National Product Manager from March 2026. This is a commercial role that could strengthen the mentorship application, but no details about the company or the role's scope are provided. Eniola should insert specific facts about this role if they are relevant to the programme's selection criteria.